PRN: Global and US High-Growth Diagnostic Testing Markets Report 2016-2021

22/gen/2016 13:10:38 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global and US High-Growth Diagnostic Testing Markets Report 2016-2021


DUBLIN, Jan. 22, 2016 /PRNewswire/ --

Research and Markets ( has announced the addition of the "High-Growth Diagnostic Testing Markets" report to their offering.

There will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with pressures to improve the quality of healthcare delivered in the clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade.

The emphasis in this report is on those companies that are actively developing and marketing high-growth diagnostic testing technologies in the clinical hospital market. It defines the dollar volume of sales, both worldwide and in the U.S., of the market and analyzes the factors that influence the size and growth of market segments. The study goes on to discuss in detail trends that have developed which have stimulated this market, and also comments in detail patterns of information processing in the high-growth diagnostic testing technologies.

Moreover, this examination provides an overview of the diagnostic testing market, including the latest information regarding exciting new products and industry trends. It will not only quantify but also qualify the market high-growth segments as an area of research and investment. Forecasts of the market and analyses of products in the worldwide prescriptions market will provide a basis for understanding the significance of past developments and future possibilities within this therapeutic category.

Key Topics Covered:

1. Overview

2. Introduction to the High-Growth Testing Market

3. Hepatitis Serologic Markers and Nucleic Acid Testing

4. Human Papillomavirus (HPV) Testing

5. HIV

6. Infectious Disease Testing

7. Cardiac Markers

8. Cytogenetic Testing

9. Fertility Testing

10. Cancer Biomarker Testing

11. Substance Abuse Testing

12. Vitamin D Diagnostic Testing

13. Renal Dialysis Testing

14. Companion Diagnostics

15. Summary Analysis of the Global IVD High-Growth Market by Geographic Region

16. Clinical Laboratory Genomics

17. Cellular Imaging Cytopathology and Histopathology

18. High-Growth Testing Diagnostic Trends

19. Important Technology Trends

20. Molecular Diagnostics a Major Diagnostic Technological Advance

21. Technology Platform Innovations in POCT

22. Data Management and Connectivity

23. Biochips for Clinical Applications

24. Company Profiles

Companies Mentioned

- A Menarini Diagnostics

- Abaxis, Inc

- Abbott Laboratories

- Accurex Biomedical Pvt Ltd

- Adeza Biomedical Corporation (Hologic)

- Agilent Technologies, Inc

- American Bio Medica Corporation

- Ani Biotech Oy Ltd

- Applied Spectral Imaging

- Avitar, Inc

- Axis-Shield Plc

- Bayer Corporation

- Beckman Coulter (now part of Danaher)

- Becton, Dickinson and Company

- Bio-Rad Laboratories, Inc

- Biomerica, Inc

- Enterix, Inc (Subsidiary of Quest Diagnostics)

- Genetix (Molecular Devices)

- Genzyme Diagnostics

- Hologic Gen Probe

- LifeScan

- Matritech

- Medix Biochemica

- Meretek Diagnostics Group (Otsuka Pharmaceutical, Inc)

- Meridian Bioscience

- Myriad Genetics, Inc

- NOVA Biomedical

- OraSure

- Roche Diagnostics

- Shanghai SIIC Kehua Biotech Co, Ltd (Kehua Biotech)

- Shionogi & Co, Ltd

- Siemens Healthcare Diagnostics

- Spectral Diagnostics, Inc

- Trinity Biotech Plc

- Väsamed, Inc

For more information visit

Media Contact:

Laura Wood, +353-1-481-1716,


blog comments powered by Disqus è un servizio offerto da Factotum Srl